409 related articles for article (PubMed ID: 35768083)
1. Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol.
Wallace S; Hall V; Charlett A; Kirwan PD; Cole M; Gillson N; Atti A; Timeyin J; Foulkes S; Taylor-Kerr A; Andrews N; Shrotri M; Rokadiya S; Oguti B; Vusirikala A; Islam J; Zambon M; Brooks TJG; Ramsay M; Brown CS; Chand M; Hopkins S
BMJ Open; 2022 Jun; 12(6):e054336. PubMed ID: 35768083
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.
Hall VJ; Foulkes S; Saei A; Andrews N; Oguti B; Charlett A; Wellington E; Stowe J; Gillson N; Atti A; Islam J; Karagiannis I; Munro K; Khawam J; Chand MA; Brown CS; Ramsay M; Lopez-Bernal J; Hopkins S;
Lancet; 2021 May; 397(10286):1725-1735. PubMed ID: 33901423
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
5. Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model.
Pople D; Monk EJM; Evans S; Foulkes S; Islam J; Wellington E; Atti A; Hope R; Robotham J; Hopkins S; Brown CS; Hall VJ;
BMJ; 2022 Jul; 378():e070379. PubMed ID: 35858689
[TBL] [Abstract][Full Text] [Related]
6. Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia.
Barber VS; Peckham N; Duley L; Francis A; Abhishek A; Moss P; Cook JA; Parry HM
BMJ Open; 2023 Sep; 13(9):e077946. PubMed ID: 37770269
[TBL] [Abstract][Full Text] [Related]
7. Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study).
Abhishek A; Boyton RJ; McKnight Á; Coates L; Bluett J; Barber VS; Cureton L; Francis A; Appelbe D; Eldridge L; Julier P; Peckham N; Valdes AM; Rombach I; Altmann DM; Nguyen-Van-Tam J; Williams HC; Cook JA
BMJ Open; 2022 May; 12(5):e062599. PubMed ID: 35504634
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccine effectiveness among healthcare workers in Albania (COVE-AL): protocol for a prospective cohort study and cohort baseline data.
Sridhar S; Fico A; Preza I; Hatibi I; Sulo J; Kissling E; Daja R; Ibrahim R; Lemos D; Rubin-Smith J; Schmid A; Vasili A; Valenciano M; Jorgensen P; Pebody R; Lafond KE; Katz MA; Bino S
BMJ Open; 2022 Mar; 12(3):e057741. PubMed ID: 35321895
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
10. University population-based prospective cohort study of SARS-CoV-2 infection and immunity (SARSSURV-ULiège): a study protocol.
Donneau AF; Guillaume M; Bours V; Dandoy M; Darcis G; Desmecht D; Diep AN; Fievez L; Garigliany MM; Gillain N; Husson E; Michel F; Moutschen M; Paridans M; Benoît P; Sabatel C; Saegerman C; Tytgat A; Gillet L; Bureau F
BMJ Open; 2022 Jan; 12(1):e055721. PubMed ID: 35078848
[TBL] [Abstract][Full Text] [Related]
11. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
Jeffery-Smith A; Rowland TAJ; Patel M; Whitaker H; Iyanger N; Williams SV; Giddings R; Thompson L; Zavala M; Aiano F; Ellis J; Lackenby A; Höschler K; Brown K; Ramsay ME; Gopal R; Chow JY; Ladhani SN; Zambon M
Lancet Healthy Longev; 2021 Dec; 2(12):e811-e819. PubMed ID: 34873592
[TBL] [Abstract][Full Text] [Related]
12. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
13. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
14. Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study.
Atti A; Insalata F; Carr EJ; Otter AD; Castillo-Olivares J; Wu M; Harvey R; Howell M; Chan A; Lyall J; Temperton N; Cantoni D; da Costa K; Nadesalingam A; Taylor-Kerr A; Hettiarachchi N; Tranquillini C; Hewson J; Cole MJ; Foulkes S; Munro K; Monk EJM; Milligan ID; Linley E; Chand MA; Brown CS; Islam J; Semper A; Charlett A; Heeney JL; Beale R; Zambon M; Hopkins S; Brooks T; Hall V;
J Infect; 2022 Nov; 85(5):545-556. PubMed ID: 36089104
[TBL] [Abstract][Full Text] [Related]
15. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
Nordström P; Ballin M; Nordström A
Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
[TBL] [Abstract][Full Text] [Related]
16. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccine effectiveness and variants in Nepal: study protocol for a test-negative case-control study with SARS-CoV-2 genetic sequencing.
Bijukchhe SM; O'Reilly PJ; Theiss-Nyland K; Gurung M; Pokhrel B; Kelly S; Acharya S; Maharjan S; Shrestha A; Pandey B; Lama M; Shrestha I; Voysey M; Eordogh A; Shrestha S; Feng ES; Li G; Shah G; Pollard AJ; Shrestha S
BMJ Open; 2023 Apr; 13(4):e068334. PubMed ID: 37072367
[TBL] [Abstract][Full Text] [Related]
18. Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol.
Setiabudi W; Hungerford D; Subramaniam K; Vaselli NM; Shaw VE; Wilton M; Vivancos R; Aston S; Platt G; Moitt T; Jones AP; Gabbay M; Buchan I; Carrol ED; Iturriza-Gomara M; Solomon T; Greenhalf W; Naisbitt DJ; Adams ER; Cunliffe NA; Turtle L; French N;
BMJ Open; 2021 Mar; 11(3):e048317. PubMed ID: 33737446
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Infection, Reinfection, and Vaccine Effectiveness in a Prospective Cohort of Arizona Frontline/Essential Workers: The AZ HEROES Research Protocol.
Lutrick K; Ellingson KD; Baccam Z; Rivers P; Beitel S; Parker J; Hollister J; Sun X; Gerald JK; Komatsu K; Kim E; LaFleur B; Grant L; Yoo YM; Kumar A; Mayo Lamberte J; Cowling BJ; Cobey S; Thornburg NJ; Meece JK; Kutty P; Nikolich-Zugich J; Thompson MG; Burgess JL
JMIR Res Protoc; 2021 May; 10(6):. PubMed ID: 34057904
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S;
Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
